Cargando…
Phantom criteria for qualification of brain FDG and amyloid PET across different cameras
BACKGROUND: While fluorodeoxyglucose (FDG) and amyloid PET is valuable for patient management, research, and clinical trial of therapeutics on Alzheimer’s disease, the specific details of the PET scanning method including the PET camera model type influence the image quality, which may further affec...
Autores principales: | Ikari, Yasuhiko, Akamatsu, Go, Nishio, Tomoyuki, Ishii, Kenji, Ito, Kengo, Iwatsubo, Takeshi, Senda, Michio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052249/ https://www.ncbi.nlm.nih.gov/pubmed/27709546 http://dx.doi.org/10.1186/s40658-016-0159-y |
Ejemplares similares
-
Voxel-based statistical analysis and quantification of amyloid PET in the Japanese Alzheimer’s disease neuroimaging initiative (J-ADNI) multi-center study
por: Akamatsu, Go, et al.
Publicado: (2019) -
Japanese guideline for the oncology FDG-PET/CT data acquisition protocol: synopsis of Version 2.0
por: Fukukita, Hiroyoshi, et al.
Publicado: (2014) -
Dosimetry and efficacy of a tau PET tracer [(18)F]MK-6240 in Japanese healthy elderly and patients with Alzheimer’s disease
por: Ohnishi, Akihito, et al.
Publicado: (2022) -
Qualifications of Safe Return to Play Criteria
por: Ercan, Sabriye, et al.
Publicado: (2017) -
Appropriateness criteria of FDG PET/CT in oncology
por: Agrawal, Archi, et al.
Publicado: (2015)